Tango Therapeutics, Inc. ($TNGX)
Crystal Adam โ President, R&D
Shares
54,345
Price
$12.77
Total Value
$694,208.46
Nearby Earnings
Feb 26, 2026
EPS:Est: -0.31
Transaction Details
| Insider | Crystal Adam |
|---|---|
| Title | President, R&D |
| Transaction Date | Feb 25, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 27, 2026 |
| Shares Sold | 54,345 |
| Price per Share | $12.77 |
| Total Value | $694,208.46 |
| Shares Owned After | 132,873 |
| Derivative | No |
| Accession Number | 0001193125-26-083579 |
| Document | View SEC Filing |